Strides Pharma Science

quarterly
yearly
ParticularsMar '23Jun '23Sep '23Dec '23Mar '24
Revenue589.94486.97562.63528.71647.26
Expenses509.73477.85558.43519.89594.42
EBITDA145.8167.2165.6074.34120.43
EBIT108.1045.7644.2647.9999.55
Profit Before Tax65.209.134.193.5252.77
Net Profit62.408.001.282.5453.66
Financial Ratios
Operating Profit Margin23.21%14.14%12.14%13.28%19.49%
Net Profit Margin12.68%1.68%0.24%1.32%8.70%
Earning Per Share (Diluted)6.910.890.140.285.83
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.1.9
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ